NS Partners’s Bristol-Myers Squibb BMY Stock Holding History

NS Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,362	Closed	-$208K	–	95
2019 Q1	$208K	Hold	4,362	–	–	0.02%	109
2018 Q4	$227K	Sell	4,362 -394	-8%	-$21.2K	0.02%	87
2018 Q3	$295K	Sell	4,756 -360	-7%	-$21.4K	0.03%	88
2018 Q2	$283K	Sell	5,116 -35,087	-87%	-$1.89M	0.03%	94
2018 Q1	$2.54M	Sell	40,203 -634	-2%	-$40.8K	0.27%	87
2017 Q4	$2.5M	Sell	40,837 -3	-0%	-$188	0.27%	85
2017 Q3	$2.6M	Sell	40,840 -794	-2%	-$46.4K	0.31%	83
2017 Q2	$2.32M	Sell	41,634 -62,710	-60%	-$3.41M	0.3%	79
2017 Q1	$5.67M	Buy	104,344 +78	+0.1%	+$4.28K	0.82%	56
2016 Q4	$6.09M	Sell	104,266 -1,990	-2%	-$109K	0.96%	43
2016 Q3	$5.73M	Sell	106,256 -337	-0.3%	-$21.6K	0.93%	43
2016 Q2	$7.84M	Sell	106,593 -13,720	-11%	-$969K	1.34%	24
2016 Q1	$7.69M	Buy	120,313 +7,632	+7%	+$481K	1.38%	22
2015 Q4	$7.75M	Sell	112,681 -17,073	-13%	-$1.13M	1.38%	20
2015 Q3	$7.68M	Sell	129,754 -961	-0.7%	-$61K	1.35%	21
2015 Q2	$8.7M	Buy	+130,715	New	+$8.61M	1.39%	20

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

NS Partners's BMY Position: Q2 2019 in Review

NS Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 4,362 shares — an estimated $208K sold.

NS Partners first reported a position in BMY in Q2 2015 and held it in 16 quarters. The position peaked at $8.7M in Q2 2015. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

NS Partners reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
NS Partners sold 4,362 Bristol-Myers Squibb shares in Q2 2019, an estimated $208K.
NS Partners first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 16 quarters.
NS Partners's Bristol-Myers Squibb position peaked at $8.7M in Q2 2015.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on NS Partners's 13F filing for Q2 2019, filed 7 Aug 2019.